Adimmune Corporation(TW:4142)
NT$16.80+0.10 (+2.75%)
TW:4142
Adimmune Corporation financials statements
NT$16.80
At close:+0.10 (+2.75%)
Adimmune Corporation (4142) Ratios
Adimmune Corporation Ratios
TW:4142's free cash flow for Q2 2026 was NT$-342.70M. For the 2026 fiscal year, TW:4142's free cash flow was decreased by NT$-25.75M and operating cash flow was NT$-316.96M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.12 | 3.11 | 2.63 | 8.97 | 12.78 |
| Quick Ratio | 1.75 | 2.57 | 2.34 | 7.66 | 11.08 |
| Cash Ratio | 1.41 | 2.02 | 1.38 | 5.71 | 8.93 |
| Solvency Ratio | -0.01 | -0.01 | -0.11 | 0.21 | 0.17 |
| Operating Cash Flow Ratio | -0.00 | 0.58 | -0.50 | -0.58 | -1.62 |
| Short-Term Operating Cash Flow Coverage | -0.00 | 0.82 | -0.74 | -2.01 | -11.69 |
| Net Current Asset Value | NT$ 130.20M | NT$ 690.24M | NT$ 992.46M | NT$ 1.89B | NT$ 2.22B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.35 | 0.31 | 0.33 | 0.25 | 0.16 |
| Debt-to-Equity Ratio | 0.57 | 0.50 | 0.57 | 0.37 | 0.21 |
| Debt-to-Capital Ratio | 0.36 | 0.33 | 0.36 | 0.27 | 0.18 |
| Long-Term Debt-to-Capital Ratio | 0.24 | 0.25 | 0.25 | 0.25 | 0.17 |
| Financial Leverage Ratio | 1.66 | 1.62 | 1.73 | 1.49 | 1.30 |
| Debt Service Coverage Ratio | -0.12 | -0.10 | -0.41 | 2.55 | 4.57 |
| Interest Coverage Ratio | -11.54 | -8.20 | -21.62 | 4.36 | -3.68 |
| Debt to Market Cap | 0.35 | 0.30 | 0.22 | 0.14 | 0.07 |
| Interest Debt Per Share | 6.80 | 6.25 | 7.54 | 5.35 | 3.11 |
| Net Debt to EBITDA | -4.45 | -2.99 | -1.34 | -1.36 | -5.22 |
| Profitability Margins | |||||
| Gross Profit Margin | 20.58% | 28.78% | 23.02% | 39.58% | 28.28% |
| EBIT Margin | -25.65% | -19.27% | -41.26% | 7.94% | 1.77% |
| EBITDA Margin | -10.32% | -5.41% | -28.71% | 19.46% | 15.53% |
| Operating Profit Margin | -25.65% | -19.21% | -40.49% | 4.38% | -3.30% |
| Pretax Profit Margin | -23.53% | -21.61% | -43.13% | 6.94% | 0.87% |
| Net Profit Margin | -17.12% | -15.59% | -35.85% | 12.92% | 2.62% |
| Continuous Operations Profit Margin | -23.53% | -21.61% | -43.13% | 6.49% | 0.87% |
| Net Income Per EBT | 72.74% | 72.14% | 83.10% | 186.26% | 301.48% |
| EBT Per EBIT | 91.72% | 112.50% | 106.54% | 158.51% | -26.41% |
| Return on Assets (ROA) | -2.93% | -2.86% | -6.75% | 3.18% | 0.54% |
| Return on Equity (ROE) | -4.85% | -4.64% | -11.69% | 4.75% | 0.70% |
| Return on Capital Employed (ROCE) | -5.41% | -4.09% | -9.39% | 1.14% | -0.70% |
| Return on Invested Capital (ROIC) | -4.56% | -3.67% | -8.10% | 1.05% | -0.70% |
| Return on Tangible Assets | -2.94% | -2.88% | -6.80% | 3.21% | 0.55% |
| Earnings Yield | -3.01% | -2.87% | -4.59% | 1.91% | 0.22% |
| Efficiency Ratios | |||||
| Receivables Turnover | 9.54 | 8.29 | 1.36 | 4.21 | 16.47 |
| Payables Turnover | 66.57 | 35.55 | 32.45 | 27.87 | 200.09 |
| Inventory Turnover | 1.95 | 1.77 | 2.61 | 2.06 | 2.33 |
| Fixed Asset Turnover | 0.35 | 0.41 | 0.49 | 0.62 | 0.48 |
| Asset Turnover | 0.17 | 0.18 | 0.19 | 0.25 | 0.20 |
| Working Capital Turnover Ratio | 0.67 | 0.58 | 0.52 | 0.60 | 0.41 |
| Cash Conversion Cycle | 220.05 | 240.46 | 396.04 | 250.51 | 177.23 |
| Days of Sales Outstanding | 38.25 | 44.03 | 267.47 | 86.72 | 22.16 |
| Days of Inventory Outstanding | 187.28 | 206.70 | 139.82 | 176.88 | 156.89 |
| Days of Payables Outstanding | 5.48 | 10.27 | 11.25 | 13.10 | 1.82 |
| Operating Cycle | 225.53 | 250.73 | 407.29 | 263.60 | 179.05 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | 1.59 | -2.12 | -0.68 | -1.12 |
| Free Cash Flow Per Share | -0.58 | 1.22 | -2.65 | -1.67 | -3.09 |
| Dividend Paid and CapEx Coverage Ratio | -0.02 | 4.31 | -4.03 | -0.70 | -0.45 |
| Capital Expenditure Coverage Ratio | -0.02 | 4.31 | -4.03 | -0.70 | -0.57 |
| Operating Cash Flow Coverage Ratio | -0.00 | 0.26 | -0.28 | -0.13 | -0.36 |
| Operating Cash Flow to Sales Ratio | -0.00 | 0.43 | -0.50 | -0.13 | -0.29 |
| Free Cash Flow Yield | -3.04% | 6.06% | -7.98% | -4.68% | -6.91% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -33.25 | -34.66 | -21.81 | 52.35 | 446.50 |
| Price-to-Sales (P/S) Ratio | 5.69 | 5.44 | 7.82 | 6.75 | 11.69 |
| Price-to-Book (P/B) Ratio | 1.61 | 1.62 | 2.55 | 2.48 | 3.12 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -32.93 | 16.51 | -12.53 | -21.37 | -14.47 |
| Price-to-Operating Cash Flow Ratio | -1464.43 | 12.67 | -15.64 | -52.09 | -39.91 |
| Price-to-Earnings Growth (PEG) Ratio | 19.28 | 0.56 | 0.07 | 0.09 | -4.62 |
| Enterprise Value Multiple | -59.57 | -103.49 | -28.57 | 33.36 | 70.02 |
| Enterprise Value | 8.62B | 8.72B | 14.64B | 14.61B | 17.85B |
| EV to EBITDA | -59.57 | -103.49 | -28.57 | 33.36 | 70.02 |
| EV to Sales | 6.15 | 5.60 | 8.20 | 6.49 | 10.87 |
| EV to Free Cash Flow | -35.59 | 17.00 | -13.14 | -20.54 | -13.46 |
| EV to Operating Cash Flow | -1582.69 | 13.05 | -16.41 | -50.06 | -37.14 |
| Tangible Book Value Per Share | 11.94 | 13.08 | 13.56 | 15.10 | 14.70 |
| Shareholders’ Equity Per Share | 11.75 | 12.41 | 13.00 | 14.33 | 14.32 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 |
| Revenue Per Share | 3.33 | 3.69 | 4.24 | 5.27 | 3.82 |
| Net Income Per Share | -0.57 | -0.58 | -1.52 | 0.68 | 0.10 |
| Tax Burden | 0.73 | 0.72 | 0.83 | 1.86 | 3.01 |
| Interest Burden | 0.92 | 1.12 | 1.05 | 0.87 | 0.49 |
| Research & Development to Revenue | 0.17 | 0.19 | 0.17 | 0.15 | 0.20 |
| SG&A to Revenue | 0.26 | 0.29 | 0.25 | 0.20 | 0.21 |
| Stock-Based Compensation to Revenue | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 |
| Income Quality | 0.02 | -1.99 | 1.16 | -1.87 | -33.64 |
Currency in TWD
